Diego Ruano

Dr. Diego Ruano


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2008 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SJSebastian Jimenez
Sebastian Jimenez
DBDavid Baglietto-Vargas
David Baglietto-Vargas
CCCristina Caballero
Cristina Caballero
Ines Moreno-GonzalezInes Moreno-Gonzalez
Ines Moreno-Gonzalez
MTManuel Torres
Manuel Torres
JVJavier Vitorica
Javier Vitorica
Although the microglial activation is concomitant to the Alzheimer's disease, its precise role (neuroprotection vs neurodegeneration) has not yet been resolved. Here, we show the existence of an age-dependent phenotypic change of microglial activation in the hippocampus ofPS1xAPPmodel, from an alternative activation state with Aβ phagocytic capabilities (at 6 months) to a classic cytotoxic phenotype (expressing TNF-α and related factors) at 18 months of age. This switch was coincident with high levels of soluble Aβ oligomers and a significant pyramidal neurodegeneration.In vitroassays, using astromicroglial cultures, demonstrated that oligomeric Aβ42 and soluble extracts from 18-month-oldPS1xAPPhippocampus produced a potent TNF-α induction whereas monomeric Aβ42 and soluble extract from 6- or 18-month-old control and 6-month-oldPS1xAPPhippocampi produced no stimulation. This stimulatory effect was avoided by immunodepletion using 6E10 or A11. In conclusion, our results show evidence of a switch in the activated microglia phenotype from alternative, at the beginning of Aβ pathology, to a classical at advanced stage of the disease in this model. This change was induced, at least in part, by the age-dependent accumulation of extracellular soluble Aβ oligomers. Finally, these cytotoxic activated microglial cells could participate in the neuronal lost observed in AD.

22 October 2011 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
RSRaquel Sanchez-Varo
Raquel Sanchez-Varo
LTLaura Trujillo-Estrada
Laura Trujillo-Estrada
ESElisabeth Sanchez-Mejias
Elisabeth Sanchez-Mejias
MTManuel Torres
Manuel Torres
DBDavid Baglietto-Vargas
David Baglietto-Vargas
AGAntonia Gutierrez
Antonia Gutierrez
Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer’s disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1M146L/APP751SL mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification of numerous autophagic vesicles filling and causing the axonal swellings. Early neuritic cytoskeletal defects determined by the presence of phosphorylated tau (AT8-positive) and actin–cofilin rods along with decreased levels of kinesin-1 and dynein motor proteins could be responsible for this extensive vesicle accumulation within dystrophic neurites. Although microsomal Aβ oligomers were identified, the presence of A11-immunopositive Aβ plaques also suggested a direct role of plaque-associated Aβ oligomers in defective axonal transport and disease progression. Most importantly, presynaptic terminals morphologically disrupted by abnormal autophagic vesicle buildup were identified ultrastructurally and further supported by synaptosome isolation. Finally, these early abnormalities in axonal and presynaptic structures might represent the morphological substrate of hippocampal dysfunction preceding synaptic and neuronal loss and could significantly contribute to AD pathology in the preclinical stages.

1 November 2006 in Neurobiology of Aging
Verified
Journal Article
Closed access
BRBlanca Ramos
Blanca Ramos
DBDavid Baglietto-Vargas
David Baglietto-Vargas
JRJuan Carlos del Rio
Juan Carlos del Rio
Ines Moreno-GonzalezInes Moreno-Gonzalez
Ines Moreno-Gonzalez
CSConsuelo Santa-María
Consuelo Santa-María
JVJavier Vitorica
Javier Vitorica

1 July 2006 in Neurobiology of Aging
Verified
Journal Article
Closed access
MGM. Paz Gavilán
M. Paz Gavilán
JVJosé Vela
José Vela
ANAngélica Castaño Navarro
Angélica Castaño Navarro
BRBlanca Ramos
Blanca Ramos
JRJuan C. del Río
Juan C. del Río
DRDiego Ruano
Diego Ruano

1 May 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SJSebastian Jimenez
Sebastian Jimenez
MTManuel Torres
Manuel Torres
MVMaría Luisa Vizuete
María Luisa Vizuete
RSRaquel Sanchez-Varo
Raquel Sanchez-Varo
ESElisabeth Sanchez-Mejias
Elisabeth Sanchez-Mejias
JVJavier Vitorica
Javier Vitorica
Neurotrophins, activating the PI3K/Akt signaling pathway, control neuronal survival and plasticity. Alterations in NGF, BDNF, IGF-1, or insulin signaling are implicated in the pathogenesis of Alzheimer disease. We have previously characterized a bigenic PS1×APP transgenic mouse displaying early hippocampal Aβ deposition (3 to 4 months) but late (17 to 18 months) neurodegeneration of pyramidal cells, paralleled to the accumulation of soluble Aβ oligomers. We hypothesized that PI3K/Akt/GSK-3β signaling pathway could be involved in this apparent age-dependent neuroprotective/neurodegenerative status. In fact, our data demonstrated that, as compared with age-matched nontransgenic controls, the Ser-9 phosphorylation of GSK-3β was increased in the 6-month PS1×APP hippocampus, whereas in aged PS1×APP animals (18 months), GSK-3β phosphorylation levels displayed a marked decrease. Using N2a and primary neuronal cell cultures, we demonstrated that soluble amyloid precursor protein-α (sAPPα), the predominant APP-derived fragment in young PS1×APP mice, acting through IGF-1 and/or insulin receptors, activated the PI3K/Akt pathway, phosphorylated the GSK-3β activity, and in consequence, exerted a neuroprotective action. On the contrary, several oligomeric Aβ forms, present in the soluble fractions of aged PS1×APP mice, inhibited the induced phosphorylation of Akt/GSK-3β and decreased the neuronal survival. Furthermore, synthetic Aβ oligomers blocked the effect mediated by different neurotrophins (NGF, BDNF, insulin, and IGF-1) and sAPPα, displaying high selectivity for NGF. In conclusion, the age-dependent appearance of APP-derived soluble factors modulated the PI3K/Akt/GSK-3β signaling pathway through the major neurotrophin receptors. sAPPα stimulated and Aβ oligomers blocked the prosurvival signaling. Our data might provide insights into the selective vulnerability of specific neuronal groups in Alzheimer disease.

1 May 1995 in Neuron
Verified
Journal Article
Closed access
DRDiego Ruano
Diego Ruano
BLBertrand Lambolez
Bertrand Lambolez
JRJean Rossier
Jean Rossier
APAna V Paternain
Ana V Paternain
JLJuan Lerma
Juan Lerma